XmAb™2513, an Fc Engineered Humanized Anti-CD30 Monoclonal Antibody, Has Potent In Vitro and In Vivo Activities, and Has the Potential for Treating Hematologic Malignancies.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2007 110(11):2340-2340 - Subject
- Language
- ISSN
- 0006-4971